68 Ga-PSMA

prostate-specific membrane antigen ligand labeled with gallium-68

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68 Ga-PSMA, covering 2022-12-29 to 2022-12-29. Get the full timeline:

Most recent: Clinical Trial Update: 68 Ga-PSMA for High Risk Prostate Cancer [Phase 1, Phase 2]